Velocity SP Herbicide

VALENT CANADA, INC

Revision date : 2018-01-23

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2018-01-23

Product name

Velocity SP Herbicide

CAS No.

125401-92-5

Emergency telephone

HEALTH EMERGENCY OR SPILL (24 hr

Icons in SDS

Company Information

company name

VALENT CANADA, INC

Section 2

SECTION 2: Hazards identification

Emergency Overview CAUTION • Causes moderate eye irritation. • Harmful if swallowed or absorbed through skin. • Avoid breathing dust or spray mist • Avoid contact with eyes, skin and clothing • Keep out of reach of children

Potential health effects

Acute Toxicity (Primary Routes of Exposure): None known Acute Eye Contact: Based on an evaluation of the ingredients and/or similar products, this product may cause brief and/or minor eye irritation. The expected adverse health effects resulting from an exposure may include redness and possible swelling. Acute Skin Contact: Based on an evaluation of the ingredients and/or similar products, this product may cause brief and/or minor skin irritation. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. Based on an evaluation of the ingredients and/or similar products, this product may be slightly toxic when absorbed through the skin. Based on an evaluation of the ingredients and/or similar products, this product is not expected to cause allergic skin reactions. Acute Ingestion: Based on an evaluation of the ingredients and/or similar products, this product may be slightly toxic when ingested. ______________________________________________________________________________________________ Acute Inhalation: Based on an evaluation of the ingredients and/or similar products, this product is expected to be slightly toxic when inhaled. Exposure to high concentrations in the air may result in respiratory irritation. Signs and symptoms may include, but not be limited to, nasal discharge, sore throat, coughing and difficulty in breathing. Chronic Toxicity (including cancer): Studies with bispyribac-sodium technical in laboratory animals indicate that repeated high exposures can produce changes in the liver, urinary bladder, bile duct and kidney but do not produce cancer. Developmental Toxicity (birth defects): No developmental toxicity was produced in laboratory animals exposed to bispyribac-sodium technical, even at doses that were toxic to the pregnant animal. Reproductive toxicity: Bispyribac-sodium technical did not produce reproductive toxicity in animal studies. Signs and Symptoms of Systemic Effects: Signs of toxicity observed in test animals exposed to repeated high doses of a similar product, bispyribac-sodium technical, include vomiting, salivation, loose stools and decreased body weight gain. Potentially Aggravated Medical Conditions: Individuals with preexisting conditions of the liver, kidney, bile duct or urinary bladder may have increased susceptibility to the toxicity of excessive exposures. For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Ecotox/Environmental Information, refer to Section 12. For Regulatory Information, refer to Section 15.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.